Home007570 • KRX
add
Ilyang Pharmaceutical Co Ltd
Previous close
₩13,050.00
Year range
₩9,540.00 - ₩15,490.00
Market cap
254.79B KRW
Avg Volume
8.03K
P/E ratio
21.50
Dividend yield
1.15%
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 62.70B | 7.24% |
Operating expense | 25.60B | 6.29% |
Net income | 576.52M | -45.61% |
Net profit margin | 0.92 | -49.17% |
Earnings per share | — | — |
EBITDA | 3.26B | -9.63% |
Effective tax rate | -218.48% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.58B | -32.68% |
Total assets | 444.81B | -10.44% |
Total liabilities | 205.41B | -10.03% |
Total equity | 239.41B | — |
Shares outstanding | 17.92M | — |
Price to book | 1.00 | — |
Return on assets | 0.66% | — |
Return on capital | 0.81% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 576.52M | -45.61% |
Cash from operations | 2.26B | -17.30% |
Cash from investing | -5.59B | 47.76% |
Cash from financing | 4.35B | 135.78% |
Net change in cash | 756.49M | 112.61% |
Free cash flow | -2.73B | 27.30% |
About
Founded
Jul 1, 1946
Website
Employees
666
